These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32348606)

  • 1. Association between hyperglycemia and the malignant transformation of oral leukoplakia in China.
    Li J; Liu Y; Zhang H; Hua H
    Oral Dis; 2020 Oct; 26(7):1402-1413. PubMed ID: 32348606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copy Number Alterations Predict Development of OSCC from Oral Leukoplakia.
    Cai X; Zhang J; Li L; Liu L; Tang M; Zhou X; Peng C; Li X; Chen X; Xu M; Zhang H; Wang J; Huang Y; Li T
    J Dent Res; 2024 Feb; 103(2):138-146. PubMed ID: 38217281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the human papillomavirus in malignant transformation of oral leukoplakia distinct from oropharyngeal squamous cell carcinoma: A study of 76 patients with internal-control specimens.
    Wu W; Wang Z; Zhou Z
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Sep; 128(3):273-279. PubMed ID: 31133518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors Associated With Malignant Transformation in Patients With Oral Leukoplakia in a Chinese Population: A Retrospective Study.
    Wu W; Wang Z; Zhou Z
    J Oral Maxillofac Surg; 2019 Dec; 77(12):2483-2493. PubMed ID: 31493377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant transformation rate of oral leukoplakia in an Australian population.
    Shearston K; Fateh B; Tai S; Hove D; Farah CS
    J Oral Pathol Med; 2019 Aug; 48(7):530-537. PubMed ID: 31172563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of PD-1/PD-L1 on immune microenvironment in oral leukoplakia and oral squamous cell carcinoma.
    Xu SB; Wang MY; Shi XZ; Wang Q; Yu M; Zhang W; Xu XH; Liu LK
    Oral Dis; 2023 Nov; 29(8):3268-3277. PubMed ID: 35921211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant transformation of oral leukoplakia treated with carbon dioxide laser: a meta-analysis.
    Dong Y; Chen Y; Tao Y; Hao Y; Jiang L; Dan H; Zeng X; Chen Q; Zhou Y
    Lasers Med Sci; 2019 Feb; 34(1):209-221. PubMed ID: 30443884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DEC1: a potential biomarker of malignant transformation in oral leukoplakia.
    Mao T; Xiong H; Hu X; Hu Y; Wang C; Yang L; Huang D; Xia K; Su T
    Braz Oral Res; 2020; 34():e052. PubMed ID: 32578762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary KLK5 and uPA are potential biomarkers for malignant transformation of OLK and OLP.
    Kang Y; Chen J; Li X; Luo M; Chen H; Cui B; Wang L; Lv D; Feng Y; Zhang P
    Cancer Biomark; 2021; 31(4):317-328. PubMed ID: 33896830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
    Cao J; Jin JQ; Deng DJ; Liu HW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A complete course of photodynamic therapy reduced the risk of malignant transformation of oral leukoplakia.
    Song Y; Tang F; Liu J; Yang D; Wang J; Luo X; Zhou Y; Zeng X; Xu H; Chen Q; Dan H
    Photodiagnosis Photodyn Ther; 2024 Oct; 49():104338. PubMed ID: 39313101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Pathomics-Based Model for the Prediction of Malignant Transformation in Oral Leukoplakia.
    Cai X; Li L; Yu F; Guo R; Zhou X; Zhang F; Zhang H; Zhang J; Li T
    Lab Invest; 2023 Aug; 103(8):100173. PubMed ID: 37164265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Ki-67, Cyclin D1, P53, and P16 in patients with oral leukoplakia and leukoplakia cancerization with spicy diet in Chengdu.
    Wan ZX; Zheng ZJ; Huang MC; Chen Y; Yao LH
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Aug; 39(4):434-440. PubMed ID: 34409799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk assessment of malignant transformation of oral leukoplakia in patients with previous oral squamous cell carcinoma.
    Yang SW; Lee YC; Lee YS; Chang LC; Lai YR
    Int J Oral Maxillofac Surg; 2022 Nov; 51(11):1394-1400. PubMed ID: 35249786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annual malignant transformation rate of oral leukoplakia remains consistent: A long-term follow-up study.
    Evren I; Brouns ER; Wils LJ; Poell JB; Peeters CFW; Brakenhoff RH; Bloemena E; de Visscher JGAM
    Oral Oncol; 2020 Nov; 110():105014. PubMed ID: 33038723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors.
    Lee JJ; Hung HC; Cheng SJ; Chen YJ; Chiang CP; Liu BY; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):472-80. PubMed ID: 16545712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compositional and functional changes in the salivary microbiota related to oral leukoplakia and oral squamous cell carcinoma: a case control study.
    Lan Q; Zhang C; Hua H; Hu X
    BMC Oral Health; 2023 Dec; 23(1):1021. PubMed ID: 38115005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A retrospective analysis on the malignant transformation rate, time and risk factors of oral leukoplakia].
    Wang YF; Shang S; Zhou ZT; Tang GY
    Shanghai Kou Qiang Yi Xue; 2011 Feb; 20(1):55-61. PubMed ID: 21451900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autofluorescence imaging as a noninvasive tool of risk stratification for malignant transformation of oral leukoplakia: A follow-up cohort study.
    Li C; Zhang Q; Sun K; Jia H; Shen X; Tang G; Liu W; Shi L
    Oral Oncol; 2022 Jul; 130():105941. PubMed ID: 35653817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive bioinformatics analysis combined with experimental validation to screen biomarkers for malignant transformation of oral leukoplakia.
    Li F; Qiu L; Gao Q; Yu L; Liu H; Xue Z; Tao A
    Genomics; 2023 Sep; 115(5):110686. PubMed ID: 37454941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.